NCT04254952 is a clinical trial in Hyperventilation Syndrome, sponsored by Hacettepe University.

Who is sponsoring NCT04254952?

NCT04254952 is sponsored by Hacettepe University.

What condition does NCT04254952 study?

NCT04254952 studies Hyperventilation Syndrome.

Is NCT04254952 still recruiting?

NCT04254952 is currently completed. Last updated 25 May 2021.

Last reviewed 2021-05-25 · How we verify

NCT04254952

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Turkish Version of Nijmegen Questionnaire

Completed Last updated 25 May 2021

What this trial tests

trial in Hyperventilation Syndrome in 54 participants. Completed in 21 February 2021.

Timeline

15 September 2019

Primary endpoint
21 February 2021

21 February 2021

Quick facts

Lead sponsor	Hacettepe University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	54
Start date	15 September 2019
Primary completion	21 February 2021
Estimated completion	21 February 2021
Sites	1 location across Turkey (Türkiye)

Conditions studied

Hyperventilation Syndrome — all drugs for Hyperventilation Syndrome →

Sponsor

Hacettepe University

Who can join

Adults 18 to 75, any sex, with Hyperventilation Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to provide Turkish version of Nijmegen Questionnaire for the evaluation of respiratory dysfunction in asthmatic subjects. The incidence of hyperventilation syndrome in asthmatic patients can be determined with the results of the study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Hacettepe University trials

Trials by the same sponsor.

NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04254952 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
Last refreshed: 25 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04254952.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing